Print

IAVI 001

An open-label phase I study comparing the safety and immunogenicity of an HIV-1 clade A DNA vaccine, pTHr.HIVA, in healthy, HIV-uninfected volunteers

Trial Details:

I Completed
Medical Research Council (MRC), Oxford, IAVI August 01, 2000
DNA.HIVA Gag A
DNA.HIVA DNA
United Kingdom 18
http://www.oxavi.org